Spindle cell sarcoma is a group of cancerous tumors made up of elongated, spindle-shaped cells that develop in soft tissues or bone. Rather than a single disease, the term describes several distinct cancer types that share a similar appearance under the microscope. Many spindle cell sarcomas are high-grade, meaning they contain highly abnormal cells and tend to grow and spread quickly.
Why It’s Called “Spindle Cell”
The name comes from how the tumor cells look under a microscope. Normal cells are roughly round, but the cells in these tumors are stretched out with tapered ends, resembling the shape of a weaving spindle. These elongated cells arrange themselves into recognizable patterns, sometimes fanning out from a central point, sometimes running in parallel bundles. The specific pattern helps pathologists narrow down which type of sarcoma they’re dealing with.
Types of Spindle Cell Sarcoma
Several distinct cancers fall under the spindle cell sarcoma umbrella. The major types include:
- Leiomyosarcoma: arises from smooth muscle tissue, commonly found in the uterus, abdomen, or blood vessel walls
- Fibrosarcoma: develops from fibrous connective tissue
- Synovial sarcoma: typically occurs near joints in young adults, despite its name having nothing to do with the joint lining
- Malignant peripheral nerve sheath tumor (MPNST): grows along the protective covering of nerves
- Rhabdomyosarcoma: originates in skeletal muscle cells
- Undifferentiated sarcoma of bone: a spindle cell cancer arising in bone with no identifiable cell lineage
When pathologists can’t determine which tissue the cancer originated from, even after extensive testing, the tumor is classified as an undifferentiated sarcoma. This essentially means the cancer cells have become so abnormal that they no longer resemble any normal tissue type.
Symptoms and How It Presents
The symptoms depend heavily on where the tumor develops. Spindle cell sarcomas in soft tissue often show up as a painless lump that grows over weeks or months. Because these lumps aren’t always painful early on, people sometimes dismiss them or assume they’re benign cysts.
When the tumor grows in or near bone, the picture changes. Bone pain is common, either constant or intermittent. Swelling and tenderness develop at the tumor site, and nearby joints may become harder to move. In some cases, the first sign is a fracture through bone that the cancer has weakened, known as a pathological fracture.
As the disease progresses, some people develop persistent fatigue or a general sense of feeling unwell that doesn’t have an obvious explanation. These systemic symptoms are less specific but can signal that the cancer is advancing.
How It’s Diagnosed
Diagnosing spindle cell sarcoma is notoriously complex because many different tumors, both cancerous and benign, are made up of spindle-shaped cells. Pathologists use a process of elimination, running a panel of specialized stains on biopsy tissue to figure out exactly what they’re looking at.
Each spindle cell sarcoma subtype produces certain proteins that act as identifying markers. Leiomyosarcoma cells, for example, test positive for muscle-related proteins. Nerve sheath tumors show specific nerve-associated markers. Rhabdomyosarcoma lights up with proteins tied to skeletal muscle development. When a tumor tests negative for all known tissue markers, it gets classified as undifferentiated, a diagnosis that can only be made after ruling out every identifiable category.
This testing also rules out non-sarcoma cancers that can mimic the appearance of spindle cell sarcoma, including certain aggressive carcinomas, melanomas, and lymphomas. Each of these has its own protein signature that distinguishes it from a true sarcoma. Genetic testing for specific chromosomal changes can further refine the diagnosis, particularly for subtypes like dedifferentiated liposarcoma.
Tumor Grading
Once a spindle cell sarcoma is confirmed, pathologists assign it a grade that predicts how aggressively it’s likely to behave. The most widely used system evaluates three features of the tumor tissue: how closely the cells resemble normal tissue (differentiation), how rapidly the cells are dividing (mitotic activity), and how much of the tumor has died from outgrowing its blood supply (necrosis). Each factor receives a score, and the combined total places the tumor into grade 1 (low), grade 2 (intermediate), or grade 3 (high).
Grade matters enormously for treatment decisions and outlook. Many spindle cell sarcomas are high-grade at diagnosis, which means they carry a greater risk of spreading to distant organs.
Treatment Approach
Surgery is the cornerstone of treatment for localized spindle cell sarcoma. The goal is to remove the entire tumor along with a margin of healthy tissue surrounding it, typically 1 to 2 centimeters of normal muscle or fat around the tumor’s edge. If the tumor sits next to a natural barrier like a thick layer of fascia or the outer lining of bone, a smaller margin may be acceptable because these structures resist cancer invasion.
Some highly invasive subtypes require wider margins of 3 centimeters or more to reduce the risk of local recurrence. When achieving wide margins would mean sacrificing too much function, particularly in areas like the hand, radiation therapy before surgery can shrink the tumor and sterilize its edges. Preoperative radiation in these situations has been shown to preserve good function afterward.
Radiation is commonly combined with surgery for high-grade tumors or cases where the margins are close. Chemotherapy may be added for certain subtypes or when the cancer has spread, though its effectiveness varies significantly depending on the specific type of sarcoma involved.
Survival and Prognosis
Prognosis depends primarily on two factors: whether the cancer has spread and what grade it is. For soft tissue sarcomas caught while still localized, the five-year relative survival rate is 83.3%, based on data from the National Cancer Institute. That number drops sharply when the cancer has already metastasized to distant sites, where the five-year survival falls to around 17%.
These figures cover all soft tissue sarcomas broadly, and individual outcomes vary based on the specific subtype, tumor size, location, and grade. Low-grade spindle cell sarcomas that are completely removed with clean margins carry a favorable prognosis. High-grade tumors, especially those larger than 5 centimeters or located deep within the body, carry higher risks of recurrence and distant spread, most commonly to the lungs.
Because early-stage tumors have dramatically better outcomes, any new, growing soft tissue lump that persists beyond a few weeks or reaches the size of a golf ball warrants imaging and evaluation, particularly if it’s deep-seated or firm to the touch.